Physician profile
Jacob Goldstein
NPI 1053674242
$19,463.98
in general payments reported to CMS, 2019-2025
32 companies · $1,509 in 2025
The $1,509 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,731 · 2020: $2,491 · 2021: $1,033 · 2022: $1,516 · 2023: $1,772 · 2024: $1,412 · 2025: $1,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,522 · Consulting Fee: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,521.61 |
| Consulting Fee | $171.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $10,886.79 | 2019-2020 | |
| Edwards Lifesciences Corporation | $3,533.11 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Abbott Laboratories | $966.53 | 2021-2025 | Amplatzer Amulet, Amplatzer Talisman, Mitraclip |
| Boston Scientific Corporation | $518.47 | 2019-2025 | Watchman Flx, Eluvia |
| Abiomed | $448.34 | 2020-2024 | Impella |
| Medtronic, INC. | $408.88 | 2021-2023 | Linq II |
| Inari Medical, INC. | $355.59 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $307.55 | 2022-2025 | Eliquis, Camzyos |
| Pfizer INC. | $271.21 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $204.26 | 2021-2025 | Farxiga |
| Jenavalve Technology, INC. | $171.32 | 2024 | |
| Amgen INC. | $168.15 | 2023-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.98 | 2019-2025 | Lifevest |
| Heartflow, INC. | $148.62 | 2025 | |
| Siemens Medical Solutions USA, INC. | $124.49 | 2019-2024 | Acuson Origin Diagnostic Ultrasound System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $113.52 | 2024-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $105.88 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.76 | 2023-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $74.46 | 2023-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $71.74 | 2023-2025 | |
| Intact Vascular, INC. | $66.50 | 2019 | |
| Shockwave Medical, INC | $60.56 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Scpharmaceuticals INC. | $39.46 | 2024-2025 | |
| Cvrx, INC. | $32.05 | 2022-2024 | Barostim Neo System |
| Intuitive Surgical, INC. | $31.79 | 2024 | |
| Esperion Therapeutics, INC. | $25.80 | 2024 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $23.18 | 2023 | Arcalyst |
| Bridgebio Pharma, INC. | $17.57 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $16.51 | 2024 | |
| Lantheus Medical Imaging, INC. | $15.21 | 2020 | |
| Biotronik INC. | $14.98 | 2022 | |
| Baylis Medical Company INC | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.